{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:30:52Z","timestamp":1780421452364,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10689-011-9495-1","type":"journal-article","created":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T08:54:39Z","timestamp":1322470479000},"page":"33-40","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer"],"prefix":"10.1007","volume":"11","author":[{"given":"Anne Kinhult","family":"St\u00e5hlbom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemming","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Liljegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"von Wachenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brita","family":"Arver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,29]]},"reference":[{"key":"9495_CR1","first-page":"232","volume":"48","author":"EB Claus","year":"1991","unstructured":"Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232\u2013242","journal-title":"Am J Hum Genet"},{"key":"9495_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00666424","volume":"28","author":"EB Claus","year":"1993","unstructured":"Claus EB, Risch N, Thompson WD (1993) The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 28:115\u2013120","journal-title":"Breast Cancer Res Treat"},{"key":"9495_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","volume":"73","author":"EB Claus","year":"1994","unstructured":"Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk predictions. Cancer 73:643\u2013651","journal-title":"Cancer"},{"key":"9495_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145\u2013158","journal-title":"Am J Hum Genet"},{"key":"9495_CR5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial, personal risk factors. Stat Med 23:1111\u20131130","journal-title":"Stat Med"},{"key":"9495_CR6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","volume":"91","author":"AC Antoniou","year":"2004","unstructured":"Antoniou AC, Pharoah PP, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580\u20131590","journal-title":"Br J Cancer"},{"key":"9495_CR7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98:1457\u20131466","journal-title":"Br J Cancer"},{"key":"9495_CR8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"AC Antoniou","year":"2003","unstructured":"Antoniou AC, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9495_CR9","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr1365","volume":"8","author":"AC Antoniou","year":"2006","unstructured":"Antoniou AC, Durocher F, Smith P, Simard J, INHERIT BRCAs program members, Easton DF (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3","journal-title":"Breast Cancer Res"},{"key":"9495_CR10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PD (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinic. J Med Genet 45:425\u2013431","journal-title":"J Med Genet"},{"key":"9495_CR11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","volume":"24","author":"CH Barcenas","year":"2006","unstructured":"Barcenas CH, Hosain GM, Arun B, Zong J, Zhou X, Chen J, Cortada JM, Mills GB, Tomlinson GE, Miller AR, Strong LC, Amos CI (2006) Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24:354\u2013360","journal-title":"J Clin Oncol"},{"key":"9495_CR12","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2118","volume":"10","author":"E Thirthagiri","year":"2008","unstructured":"Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon S-Y, Mohd Taib NA, Thong MK, Yip CH, Teo SH (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10:R59","journal-title":"Breast Cancer Res"},{"key":"9495_CR13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1055-9965.EPI-08-1090","volume":"18","author":"AW Kurian","year":"2009","unstructured":"Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps A, West DW, Whittenmore AS (2009) Performance of prediction models for BRCA mutation carriage in three racial\/ethnic groups: findings from the Northern California breast cancer family registry. Cancer Epidemiol Biomarkers Prev 18:1084\u20131091","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9495_CR14","unstructured":"BOADICEA http:\/\/www.srl.cam.ac.uk\/genepi\/boadicea\/boadicea_home.html . Accessed 7 July 2011"},{"key":"9495_CR15","unstructured":"The National Oncogenetic Group, Arver B, Einbeigi Z, Loman N, Malander S. 20080901. State-of-the-art. Utredning, uppf\u00f6ljning och omh\u00e4ndertagande av personer med misst\u00e4nkt \u00e4rftlig \u00f6kad risk f\u00f6r tum\u00f6rsjukdom. Br\u00f6stcancer och \u00e4ggstockscancer"},{"key":"9495_CR16","unstructured":"National Human Genome Research Institute http:\/\/research.nhgri.nih.gov\/bic\/ . Accessed 7 July 2011"},{"key":"9495_CR17","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr2576","volume":"12","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12:R28","journal-title":"Breast Cancer Res"},{"key":"9495_CR18","unstructured":"BOADICEA http:\/\/www.srl.cam.ac.uk\/genepi\/boadicea\/boadicea_faqs.html#q32 . Accessed 12 July 2011"},{"key":"9495_CR19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","volume":"40","author":"E Amir","year":"2003","unstructured":"Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807\u2013814","journal-title":"J Med Genet"},{"key":"9495_CR20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","volume":"21","author":"SM Domchek","year":"2003","unstructured":"Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21:593\u2013601","journal-title":"J Clin Oncol"},{"key":"9495_CR21","unstructured":"Nationella riktlinjer f\u00f6r br\u00f6stcancer (national guidelines for breast cancer) http:\/\/www.socialstyrelsen.se\/Lists\/Artikelkatalog\/Attachments\/9085\/2007-114-51_200711453.pdf . Accessed 7 July 2011"},{"key":"9495_CR22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","volume":"91","author":"J Constantino","year":"1999","unstructured":"Constantino J, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541\u20131548","journal-title":"J Natl Cancer Inst"},{"key":"9495_CR23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","volume":"93","author":"B Rockhill","year":"2001","unstructured":"Rockhill B, Spiegelman D, Byrna C, Hunter DJ, Colditz GA (2001) Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358\u2013366","journal-title":"J Natl Cancer Inst"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-011-9495-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T02:59:58Z","timestamp":1560999598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-011-9495-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9495"],"URL":"https:\/\/doi.org\/10.1007\/s10689-011-9495-1","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,29]]}}}